Relmada Therapeutics logo
Relmada Therapeutics
RLMD | NASDAQ
Chart Builder DCF Calculator
$3.61
-$0.60 (-14.25%)
At close: Nov 16, 2026, 4:00 PM ET
$3.61
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Relmada Therapeutics Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
– – – – – –
– – – – – –
– – – – – –
-59.1M -83.89M -103.7M -161.25M -125.7M -60.84M
1.4M 3.53M 5.15M 2.66M 1.2M 1.4M
-57.39M -79.98M -98.79M -157.04M -125.75M -59.46M
-57.39M -79.98M -98.79M -157.04M -125.75M -59.46M
311.9K 37.72M 48.9M 47.93M 35.08M 24.87M
744.56K 46.18M 54.81M 113.32M 90.62M 35.97M
58.04M – – 923 – –
59.1M 83.89M 103.7M 161.25M 125.7M 60.84M
– – – – – –
– – – – – –
59.1M 83.89M 103.7M 161.25M 125.7M 60.84M
– – – – – –
39.48M 30.16M 30.1M 29.63M 17.55M 15.59M
39.48M 30.16M 30.1M 29.63M 17.55M 15.59M
-1.45 -2.65 -3.28 -5.30 -7.16 -3.81
-1.45 -2.65 -3.28 -5.30 -7.16 -3.81
-57.39M -79.98M 4.91M -157.04M -125.75M -59.33M
-57.39M -79.98M -98.79M -157.04M -125.75M -59.34M
– – 103.7M 2K 1.26K 3.75K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.